Sang-Rim Kim, Kwang Woo Nam, Yong-Geun Park, Sung-Rak Lee*, In Im**, Yong-Chan Ha*** Department of Orthopaedic Surgery, College of Medicine, Jeju National.

Slides:



Advertisements
Similar presentations
Osteoporosis 9 th January 2013 Dr Julian Tomkinson.
Advertisements

The Epidemiology and Prognosis of Bilateral Legg-Calve-Perthes Disease :A comparative study with unilateral LCPD Sung-Taek Jung, Ju-Kwon Park, Nam-Young.
Project Engage Basha Silverman, Director of Prevention and Advocacy, Brandywine Counseling and Community Services Terry Horton, MD, FACP Chief, Division.
Evaluation of Femur Fracture Risk in Soft-Tissue Sarcoma of the Thigh Treated with Intensity- Modulated Radiation Therapy (IMRT) Michael R. Folkert, MD.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence November–December 2014.
® Introduction Low Back Pain and Physical Function Among Different Ethnicities Adelle A Safo, Sarah Holder DO, Sandra Burge PhD The University of Texas.
Hip Fracture Prevention The Benefits of Hip Protectors.
Groupe de recherche PRIMUS. Time to Insulin Initiation in Diabetic Patients: A Quebec Population-Based Analysis Present by: Shabnam Asghari M.D. Ph.D.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence March–April 2009.
Atypical Fractures of the Femur: Evaluation and Treatment by Travis Blood, R.J. Feller, Eric Cohen, Christopher T. Born, and Roman Hayda JBJS Reviews Volume.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence November-December 2007.
Prescribing patterns of anti-osteoporotic medications in patients pre and post discharge from a large teaching hospital for fragility type fractures between.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence November–December 2009.
Breast Cancer 101 Barbara Lee Bass, MD, FACS Professor of Surgery
Life Insurance for Life The Power of Living Benefits.
OSC Recommendations for Bone Mineral Density Reporting Slides prepared by Kerry Siminoski, MD, FRCPC William Leslie, M.Sc., MD,
Fall Prevention subtitle.
® Introduction Low Back Pain Remedies and Procedures: Helpful or Harmful? Lauren Lyons, Terrell Benold, MD, Sandra Burge, PhD The University of Texas Health.
Description of fracture with endocrine therapy use in older breast cancer survivors in a population-based setting Taryn Becker 123, Geoff Anderson 123,
Lifestyles in Malta 2007 A Survey Study Judith Rocchiccioloi, PhD., RN Karen Jagiello, RN, MSN James Madison Univesity.
Ankle fractures have features of an osteoporotic fracture Kyoung Min Lee MD Department of Orthopaedic Surgery Seoul National University Bundang Hospital.
A Comparison of the Effectiveness of Estrogen-Progesterone and Estrogen-Testosterone Combination Therapies in the Prevention of Osteoporosis in Postmenopausal.
Hormonal Replacement Therapy for postmenopausal females: To give or not to give? Amna B. Buttar, MD, MS Assistant Professor of Clinical Medicine Indiana.
“Known knowns, known unknowns, unknown unknowns….. Ronald Dumsfeld Senior Lecturer in Metabolic Bone Diseases.
1 Tuesday 28 Oct 2008 Hall I Session I: 8:00- 10:00 Symposium... 1 Tuesday 28 Oct 2008 Hall I Session I: 8:00- 10:00 Symposium...
The Different Modalities of Treatment of Osteoporosis Fracture Kuo-Ti Peng, M.D. Kuo-Ti Peng, M.D. Department of Orthopedics, Chang Gung Memorial Hospital.
Characteristics of Patients Using Extreme Opioid Dosages in the Treatment of Chronic Low Back Pain In this sample of 204 participants, 70% were female,
1 Prescribing Omissions according to START and related hospital admission in geriatric patients O. Dalleur 1, A. Spinewine 2, S. Henrard 3, C. Losseau.
1 AOA Own the Bone™ INSERT YOUR SITE NAME HERE. 2 Welcome/Goals Welcome Introduction of Team Members Goals of Meeting ● Discuss osteoporosis and low bone.
UNDERTREATMENT AMONG WOMEN DIAGNOSED WITH OSTEOPOROSIS IN GERMANY Ankita Modi 1, Chun-Po Steve Fan 2, Shuvayu Sen 1 1 Global Health Outcomes, Merck & Company,
Characteristics of a Swedish Patient Registry and Its Application On Unmet Needs Analysis Dr. Dan Mellström 1, Arun Krishna 2, Zhyi Li 3, Chun-Po Steve.
TAKING CARE OF YOU Kingston Hospital NHS Trust NHS Secondary Prevention of Osteoporotic Fragility Fractures - results from 5 years of audit data Hamid.
Hippisley-Cox, J., Bayly, J., Potter, J., Fenty, J. & Parker, C. (2007) Evaluation of standards of care for osteoporosis and falls in primary.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence May–June 2012.
Osteoporosis Disease Management: What Every Orthopaedic Surgeon Should Know by Richard M. Dell, Denise Greene, David Anderson, and Kathy Williams J Bone.
UNIVERSITY of DERBY Implementing TA 161 and 204 in the real world Dr. Jonathan Bayly Visiting Fellow, University of Derby.
RTI Health Solutions Research Triangle Park North Carolina, US US Manchester, UK UK 44(0) LEADING RESEARCH… MEASURES.
US Department of Veterans Affairs Hip Fractures in VA/Medicare-Eligible Veterans: Mortality and Costs Elizabeth Bass, PhD, 1 Dustin D. French, PhD, 1 Douglas.
Peripheral Arterial Disease Patients’ awareness of smoking as a risk factor Class 5, 1 st year 2009/2010 Adviser: Sérgio Sampaio.
Assessment of clinical risk factors for osteoporosis in patients with consisted fracture Author: Roxana Costache, 5 th year student, General Medicine Coordinators:
In the name of God. during 02/11/11 until 06/23/11 The first 4 months.
Wayne Rosamond, et al. Circulation 2007;115; e69-e171.
Screening the US Workforce for Skin Cancer: The National Health Interview Survey 1997 to 2003 Caban-Martinez AJ 1, Lee DJ 1,3, Fleming LE 1, LeBlanc WG.
Presented by Intern Huang, Yu-Hao
Osteoporosis. Background ► The problem  Osteoporosis is common  Over 50% of women and 30-45% of men over age 50 have osteopenia/osteoporosis  White.
Osteoporosis: Measuring the Problem
Comparing State and National Injury Statistics Examples from Colorado Holly Hedegaard, MD, MSPH EMS and Trauma Data Program Emergency Medical and Trauma.
Higher Incidence of Venous Thromboembolism (VTE) in the Outpatient versus Inpatient Setting Among Patients with Cancer in the United States Khorana A et.
Peripheral Arterial Disease Patients’ awareness of smoking as a risk factor Class 5, 1 st year 2009/2010 Adviser: Sérgio Sampaio.
1 Impact of Implementing Designed Nursing Intervention Protocol on Clinical Outcome of Patient with Peptic Ulcer By Amal Mohamed Ahmad Assistant Professor,
Osteoporosis Disease Management: The Role of the Orthopaedic Surgeon by Richard Dell, Denise Greene, Steven R. Schelkun, and Kathy Williams J Bone Joint.
Prevention and Treatment of Osteoporosis
Improving Evaluation and Treatment for Osteoporosis Following Distal Radial Fractures by Tamara D. Rozental, Eric C. Makhni, Charles S. Day, and Mary L.
Welcome To Our Presentation
1 Cost efficacy of smoking cessation interventions Robert West University College London Logroño, October
Carina Signori, DO Journal Club August 2010 Macdonald, M. et al. Diabetes Care; Jun 2010; 33,
Moji Saberin-Williams, M.D. Paoli Hospital Obstetrician/Gynecologist
Financial Incentives: Pay for Performance (P4P) and the Effects with the Chronically Ill Patients David Conley, MSc Alberto Coustasse, MD, Dr. PH, MBA.
Chapter ?? 23 Osteoporosis Nichols and Pavlovic C H A P T E R.
OSTEOPOROSIS Dr Annie Cooper Consultant Rheumatologist Royal Hampshire County Hospital Winchester.
R1 김형오 / Prof. 김덕윤 1.  Osteoporosis  Asian region is considered to be on the verge of an emerging osteoporosis epidemic  50% of the world’s osteoporotic.
Osteopenia in Sheehan’s Syndrome
Femoral Fractures: A Retrospective Survey on 12-month Prevalence, Patient Characteristics and Aetiology at Parirenyatwa Hospital, Harare. Mwadziwana Loiuslaw.
Dr Mohamed Ouda MRCGP 1-Reason for choice of audit 3-Standards set
Copyright © 2015 by the American Osteopathic Association.
THE EFFECTIVENESS OF ANNUAL ZOLEDRONIC ACID INFUSION VERSUS ORAL BISPHOSPHONATE: A MODELLING APPROACH Terence Ong1, 2, Matthey Jones3, Opinder Sahota1.
Osteoporosis Definition
Patient characteristics associated with inpatient mortality within 1 year after hip fracture surgery (multivariable logistic regression model adjusted.
Reporting the Results of DXA Scan
Thank you for viewing this presentation.
Presentation transcript:

Sang-Rim Kim, Kwang Woo Nam, Yong-Geun Park, Sung-Rak Lee*, In Im**, Yong-Chan Ha*** Department of Orthopaedic Surgery, College of Medicine, Jeju National University, Department of Orthopaedic Surgery, Halla General Hospital, Jeju *, Department of Orthopaedic Surgery, Hankook General Hospital, Jeju **, Department of Orthopaedic Surgery, College of Medicine, Chung-Ang University *** Orthopaedic surgeon’s awareness can improve osteoporosis treatment following hip fracture. A prospective cohort study

Treatment Rate of Osteoporosis after Hip Fracture 6% Gardner MJ et al in 2002 (JBJS-A) 19.9% Judy AG et al in 2002 (Oteoporosis Int) 8.6% Ha et al in 2002 ( J Korean Orthop Assoc) Detection and management of osteoporosis in Jeju (2005) Introduction

Results of Retrospective Cohort Study in 2005 Hip fracture patients over 50 years : 174 patients Detection of osteoporosis : 35 patients (20%) Management of osteoporosis: 27 patients (15.5%) Prescription drug : Bisphosphonate 25 patients (92.5%) HRT 1 patients, SERM 1 patients Introduction

Results of Retrospective Cohort Study in 2005 Introduction 설문조사 (17 명 ) Detection of osteoporosis : 15 명 (88.2%) Management of osteoporosis: 17 명 (100%) 처방약제 Bisphosphonate 17 명 (100%) 실제관리율 Detection of osteoporosis : 35 명 (20%) Management of osteoporosis: 27 명 (15.5%) 처방약제 Bisphosphonate 25 명 (92.5%) HRT-1 명. SERM-1 명 ≠ ≠≠ ≠

The Purpose of Study To determine whether a orthopaedic surgeon education program would increase the percentage of patients receiving treatment for osteoporosis following a hip fracture To know barriers against management of osteoporosis in patients with a hip fracture

Prospective Intervention Study Materials & Methods Duration : 1st Jan, st Dec, 2007 Material : Patients over 50 years of age who lived in Jeju island and sustained a femoral neck or intertrochateric fracture Method : Reviewed hospital record. –The admitting diagnosis, mechanism of injury, detection of osteoporosis, procedures performed during hospitalization, and discharge medications –2007 population data in Jeju-Do by national statistical office

Prospective Intervention Study Materials & Methods Detection of osteoporosis : dual energy X-ray absorptiomety (DXA) Treatment : selective estrogen receptor modulator, or hormone replacement therapy, or bisphosphonate, or calcitonin therapy Follow-up: average 1 year – repeated review of the medical records at 6 months and one year after discharge

Statistical power & sample size justification 15.5 % of initiation of osteoporosis treatment in the 2005 data Significance level of 5% 80% statistical power Estimated sample size according to treatment rate after intervention Materials & Methods Expected treatment rate after intervension Size of difference Sample size 20.5%5% %10% %15% %20% %25%31  minimum 180 patients  “ 208 patients in our study ” (drop-out rate of 20%)

22 orthopedic surgeons who worked at 8 hospitals Orthopaedic surgeon education : Two times Campaign poster or Brochure for the mouse pad Intervention Materials & Methods

Patient Follow-up Materials & Methods Patients were interviewed by telephone or direct contact to evaluate their compliance to the osteoporosis treatment at six months after discharge and were followed-up for a minimum of one year

Results Patient No. : 208 cases Mean age : 79.1 years(range, years) Gender : Man - 34 cases, Woman cases Mean hospital follow-up : 8.8 months(range, 1-24 months) Neck fracture : 107 cases(51%) Intertrochanter Fx : 101cases(49%)

Coexisting medical diseasePatients Hypertension and heart problem 84(40.4%) Diabetes 35(16.8%) Depression & dementia 32(15.4%) Previous stroke 27(13%) Pneumonia & COPD 18(8.7%) Cancer 6(2.9%) Others 18(8.7%) Result

DXA Prior to hip fracture7(3.4%) After hip fracture94(45.2%) Osteoporosis(-2.5≥ T-score)93(44.7%) Osteopenia(-1> T-score>2.5)1(0.5%) Bisphosphonate medication Prior to hip fracture2(1%) After hip fracture67(32.2%) Duration of bisphosphonate medication < 6 months25(12%) ≥ 6 months42(20.2%) Mean period of medication (months)9.5(range, 1-24) Result

Before intervention (2005 data) After intervention (2007 data) Detection of osteoporosis (DXA) 20%(35/174)45.2%(94/208) Initiation of osteoporosis management 15.5%(27/174)32.2%(67/208) Comparison data before and after intervention demonstrate that detection and initiation of medication osteoporosis are increased more than two fold. Result

Mortality < 22 patients(10,6%) within 6months 30 patients(14.4%) at 12 months 38 patients at the final follow-up Result Osteoporosis medication group (7/67) Non-osteoporosis medication group Non-osteoporosis medication group (31/141)

Interview Participation in interview : 137 patients - Passed away : 38 patients - live alone the old with dementia or deafness : 8 patients - to moved and changed telephone : 25 patients Result

Question Response No(%) of patient with medication (56) No(%) of patient without medication (81) No(%) of questionnaire (137) Have you heard osteoporosis from your doctor? Yes 26(46.4)29(35.8)55(40.1) No 30(53.6)52(64.2)82(59.9) Did you examine bone mineral density at the hospital? Yes 25(44.6)24(29.6)49(60.5) No 27(48.2)50(61.7)77(56.2) Have you received anti- osteoporosis drug? Yes 40(71.4)040(29.2) No 16(28.6)73(90.1)89(65) Why don’t you start osteoporosis treatment? Don’t feel necessity to treat osteoporosis 047(58)47(34.3) Economic reason 04(4.9)4(2.9) Transport problem 04(4.9)4(2.9) Medical insurance problem 01(1.2)1(0.7) Others 014(17.3)14(10.2) Result

Discussions Intervention methods to improve osteoporosis System of the country Harrington JT et al in 2002 Arhritis Rheum Patient`s education Gardner MJ et al in 2005 JBJS-A Doctor`s awareness Gardner MJ et al in 2002 JBJS-A

Intervention for clinicians to increase treatment rates Orthopaedic surgeon ─role the first health-care providers to evaluate patients with fractures ─their improved awareness for identifying patients with osteoporosis has shown to benefit from intervention Intervention for improving osteoporosis management following hip fracture : Orthopaedic surgeon > Physician - Miki RA et al in 2008 JBJS Discussion

Barrier to initiate osteoporosis treatment ─ patients, physician, orthopaedic surgeon and medical care system - Bogoch ER et al in 2006 JBJS ─ ten kinds of barrier - Kaufman JD et al in 2003 JBJS  they insisted importance of the orthopaedic surgeon’s role to overcome of the barriers. Most common barrier according to questionaire : Patients did not feel to necessity of osteoporosis medication Discussion

Consideration for the limitation 1.Orthopaedic surgeon association society and public mess media are also enlightening the importance of osteoporosis medication following fragility fracture 2.Medical care system is quite different developed country 3.This study is performed various leveled hospital in same cohort patients could not contact with directly and indirectly method.. 5.Interventional education program was not validated Discussion

Thank you for your attention!!